Prophylactic effect of Enterococcus faecalis FK-23 preparation on experimental candidiasis in mice

Microbiology and Immunology

Volumn 40, Issue 3, 1996, Pages 217-222

  Satonaka, Katsuhito ^a   Ohashi, Kazutomo ^a   Nohmi, Takao ^a   Yamamoto, Tetsuro ^a   Abe, Shigeru ^b   Uchida, Katsuhisa ^b   Yamaguchi, Hideyo ^b  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Anti Candida activity; Candida albicans; Enterococcus

Indexed keywords

CYCLOPHOSPHAMIDE; FK 23; IMMUNOSTIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; EXPERIMENTAL INFECTION; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOPENIA; MOUSE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS;

EID: 0029877014     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb03337.x     Document Type: Article

References (16)

1. Akagawa, G., Abe, S., and Yamaguchi, H. 1995. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli and administration of its lipopolysaccharide. J. Infect. Dis. 171: 1539-1544.
2. Aoyagi, K., Abe, F., Nemoto, K., Abe, S., Ishizuka, M., Takeuchi, T., and Yamaguchi, H. 1994. The novel immunostimulant N-563, an analogue of deoxyspergualin, promotes resistance to Candida albicans infection in mice. J. Antibiotics 47: 1077-1083.
3. Aoyagi, K., Itoh, N., Abe, F., Abe, S., Uchida, K., Ishizuka, M., Takeuchi, T., and Yamaguchi, H. 1992. Enhancement by Ubenimex (BESTATIN) of host resistance to Candida albicans infection. J. Antibiotics 45: 1778-1784.
4. Chen, H.Y., Kaneda, S., Mikami, Y., Arai, T., and Igarashi, K. 1987. Protective effect of various BRMs against Candida albicans infection in mice. Jpn. J. Med. Mycol. 28: 306-315.
5. Diamond, R.D. 1995. Mechanisms involved in neutrophil-mediated killing of Candida albicans hyphae. Jpn. J. Med. Mycol. 36: 1-6.
6. Hamood, M., Bluche, P.F., de Vroey, C., Corazza, F., Bujan, W., and Fondu, P. 1994. Effect of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: accelerated recovery from neutropenia and potentiation of anti-C. albicans resistance. Mycoses 37: 93-99.
7. Hasegawa, T., Kanasugi, H., Hidaka, M., Ogura, Y., Inomata, T., Yamamoto, T., Abe, S., and Yamaguchi, H. 1994. Evaluation of clinical usefulness on the oral BRM therapy using heat-killed Enterococcus faecalis FK-23 preparation. J. Anim. Res. Found. 3: 11-20 (in Japanese).
8. Ohasi, K., Satonaka, K., Yamamoto, T., Yamazaki, M., Kimura, S., Abe, S., and Yamaguchi, H. 1993. Antitumor activity of Enterococcus faecalis FK-23 preparation against murine syngeneic tumors. Yakugaku Zasshi 113: 396-399 (in Japanese).
9. Ohasi, K., Ueda, H., Yamazaki, M., Kimura, S., Abe, S., and Yamaguchi, H. 1992. Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier. Yakugaku Zasshi 112: 919-925 (in Japanese).
10. SAS Institute Inc. 1990. The GLM procedure, p. 891-996; p.1195-1210. In SAS/STAT user's guide, version 6, 4th ed, SAS Institute Inc., Cary, N.C.
11. Satonaka, K., Yamamoto, T., Kuroki, M., Tamura, H., Abe, S., and Yamaguchi, H. 1995. Increases in production of tumor necrosis factor in germ-free mice fed Enterococcus faecalis FK-23 preparation. Nippon Nogeikagaku Kaishi 69: 443-446 (in Japanese).
12. Shimada, T., Iwatani, K., Yanagisawa, T., Kawai, Y., Abe, S., and Yamaguchi, H. 1992. Antihypertensive activity of Enterococcus faecalis FK-23 preparation in spontaneously hypertensive rats. J. Jpn. Soc. Nutr. Food Sci. 45: 519-522 (in Japanese).
13. Shiraishi, A., Mikami, Y., and Arai, T. 1979. Protective effect of OK-432 (a streptococcal preparation) on experimental candidiasis. Microbiol. Immunol. 23: 549-554.
14. Tansho, S., Abe, S., and Yamaguchi, H. 1994. Inhibition of Candida albicans growth by murine peritoneal neutrophils and augmentation of the inhibitory activity by bacterial lipopolysaccharide and cytokines. Microbiol. Immunol. 38: 379-383.
15. Uchida, K., Abe, S., Komatsu, Y., Akagawa, G., and Yamaguchi, H. 1995. Therapeutic efficacy of oral treatment with a traditional medicine, Juzen-taiho-to against experimental deep-seated mycoses in mice. Jpn. J. Med. Mycol. 36: 47-51 (in Japanese).
16. Uetuka, A., Satoh, S., and Ohno, Y. 1979. Protective effect of PSK, a protein-bound polysaccharide preparation against candidiasis in tumor-bearing mice. Adv. Exp. Med. Biol. 121: 21-31.